HPV-18E6 Inhibits Interactions between TANC2 and SNX27 in a PBM-Dependent Manner and Promotes Increased Cell

Justyna Karolina Broniarczyk1,2, Paola Massimi1, Oscar Trejo-Cerro1

  • 1International Centre for Genetic Engineering and Biotechnology, Padriciano, Trieste, Italy.

Journal of Virology
|November 3, 2022
PubMed

Insights

Human papillomavirus (HPV) E6 oncoproteins disrupt cell polarity by interfering with SNX27-TANC2 interactions. This E6-mediated inhibition of SNX27-TANC2 binding promotes TANC2 accumulation and enhances cell proliferation, contributing to malignancy.

Area of Science:

  • Oncology
  • Virology
  • Cell Biology

Background:

  • Human papillomavirus (HPV) oncoproteins, particularly E6, are implicated in cancer development.
  • The E6 PDZ-binding motif (PBM) interacts with cellular proteins regulating cell polarity.
  • Recent findings link E6's PBM to SNX27 and endocytic transport disruption.

Purpose of the Study:

  • To identify SNX27-interacting proteins affected by HPV E6.
  • To investigate the role of the E6 PBM in these interactions.
  • To elucidate the impact of E6-SNX27-TANC2 interactions on cellular processes.

Main Methods:

  • Proteomic analysis using GFP-tagged SNX27 and mass spectrometry in HeLa cells.
  • siRNA-mediated knockdown of E6AP to assess E6-dependent interactions.
  • Validation of SNX27-TANC2 interaction and E6's effect on their association.

Main Results:

  • TANC2 was identified as an SNX27-interacting partner.
  • HPV E6 inhibits the SNX27-TANC2 association in a PBM-dependent manner.
  • E6-mediated inhibition leads to increased TANC2 protein levels and enhanced cell proliferation.

Conclusions:

  • HPV E6 disrupts the SNX27-mediated lysosomal degradation of TANC2.
  • The E6 PBM is crucial for inhibiting SNX27-TANC2 binding and promoting proliferation.
  • This study reveals a novel mechanism by which HPV E6 manipulates endocytic transport to drive cancer progression.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.6K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K